Pruitt Michael D

Average Profitability
<0.0001%
Insider Buys Quantity
74
Insider Buys Sum
$201,131.84
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Pruitt Michael D

The largest purchase of all time was on 2010-06-30 and amounted to 16797 shares of Sonnet BioTherapeutics Holdings, Inc. for $58,790.

Biography of Pruitt Michael D

No biography is available at this moment.

2020-03-23PurchaseSonnet BioTherapeutics Holdings, Inc.
SONN
CEO, Chairman
7,000
0.0699%
$0.58$4,078-78.31%
2020-01-31PurchaseSonnet BioTherapeutics Holdings, Inc.
SONN
CEO, Chairman
206
$0$0-82.68%
2019-12-10PurchaseSonnet BioTherapeutics Holdings, Inc.
SONN
CEO, Chairman
200
0.0004%
$0.62$124-77.56%
2019-11-19PurchaseSonnet BioTherapeutics Holdings, Inc.
SONN
CEO, Chairman
2,000
0.0039%
$0.70$1,410-80.36%
2019-11-17PurchaseSonnet BioTherapeutics Holdings, Inc.
SONN
CEO, Chairman
165
0.0003%
$0.64$106-76.27%
2019-08-23PurchaseSonnet BioTherapeutics Holdings, Inc.
SONN
CEO, Chairman
1,000
0.0008%
$0.57$572-65.73%
2019-08-19PurchaseSonnet BioTherapeutics Holdings, Inc.
SONN
CEO, Chairman
5,000
0.0036%
$0.61$3,050-70.41%
2019-07-30PurchaseSonnet BioTherapeutics Holdings, Inc.
SONN
CEO, Chairman
105
0.0001%
$1.12$118-72.95%
2019-06-04PurchaseSonnet BioTherapeutics Holdings, Inc.
SONN
CEO, Chairman
1,100
0.0007%
$1.00$1,105-45.41%
2019-05-28PurchaseSonnet BioTherapeutics Holdings, Inc.
SONN
CEO, Chairman
500
0.0004%
$1.10$550-40.95%
2019-05-24PurchaseSonnet BioTherapeutics Holdings, Inc.
SONN
CEO, Chairman
500
0.0004%
$1.16$580-44.49%
2018-12-31PurchaseSonnet BioTherapeutics Holdings, Inc.
SONN
CEO, Chairman
1,000
0.0007%
$1.30$1,305-40.85%
2018-12-14PurchaseSonnet BioTherapeutics Holdings, Inc.
SONN
CEO, Chairman
500
0.0004%
$2.00$1,000+208.4%
2018-11-30PurchaseSonnet BioTherapeutics Holdings, Inc.
SONN
CEO, Chairman
500
0.0003%
$1.76$880-57.9%
2018-11-27PurchaseSonnet BioTherapeutics Holdings, Inc.
SONN
CEO, Chairman
1,000
0.0007%
$1.75$1,750-57.89%
2018-11-16PurchaseSonnet BioTherapeutics Holdings, Inc.
SONN
CEO, Chairman
400
0.0003%
$1.94$776+216.31%
2018-05-08PurchaseSonnet BioTherapeutics Holdings, Inc.
SONN
CEO, Chairman
1,500
0.0011%
$3.50$5,250-92.4%
2018-03-30PurchaseSonnet BioTherapeutics Holdings, Inc.
SONN
CEO, Chairman
6,757
0.0049%
$3.70$25,001-30.88%
2017-09-26PurchaseSonnet BioTherapeutics Holdings, Inc.
SONN
CEO, Chairman
100
<0.0001%
$1.96$196+1,185.43%
2017-09-07PurchaseSonnet BioTherapeutics Holdings, Inc.
SONN
CEO, Chairman
100
<0.0001%
$2.25$225+1,063.28%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.